What minimum workflow (repeat-testing interval, escalation thresholds, and referral triggers) do you recommend for implementing NIT-based prognostic stratification for MASLD in primary care/endocrinology so that a high-risk result reliably leads to an actionable care pathway?

Typically, I recommend following what the guidelines say, which is to get a FIB-4 score in the endocrine or primary care clinic in patients who have metabolic risk factors. If the FIB-4 score is less than 1.3, you can proceed with an annual FIB-4 score for monitoring. If it ever increases the 1.3 th...